Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Prednisolone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dilacort 2.5mg gastro-resistant tablets (Cresent Pharma)
0603020T0BNAAAF
|
Dilacort (Crescent Pharma Ltd) | Prednisolone | Endocrine System | 4 |
|
Deltacortril 2.5mg gastro-resistant tablets
0603020T0BCAAAF
|
Deltacortril | Prednisolone | Endocrine System | 3 |
|
Pevanti 25mg tablets
0603020T0BLAEAR
|
Pevanti | Prednisolone | Endocrine System | 2 |
|
Prednisolone 15mg/5ml oral liquid
0603020T0AAAYAY
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | 2 |
|
Pevanti 10mg tablets
0603020T0BLACBK
|
Pevanti | Prednisolone | Endocrine System | 1 |
|
Pevanti 2.5mg tablets
0603020T0BLAAAB
|
Pevanti | Prednisolone | Endocrine System | 1 |
|
Pevanti 20mg tablets
0603020T0BLADAX
|
Pevanti | Prednisolone | Endocrine System | 1 |
|
Prednisolone 20mg/5ml oral liquid
0603020T0AABGBG
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | 1 |
|
Dilacort 2.5mg gastro-resistant tablets (Auden McKenzie)
0603020T0BKAAAF
|
Dilacort (Auden Mckenzie) | Prednisolone | Endocrine System | No data available |
|
Dilacort 2.5mg gastro-resistant tablets (Teva)
0603020T0BPAAAF
|
Dilacort (Teva UK Ltd) | Prednisolone | Endocrine System | No data available |
|
Dilacort 5mg gastro-resistant tablets (Auden McKenzie)
0603020T0BKABAG
|
Dilacort (Auden Mckenzie) | Prednisolone | Endocrine System | No data available |
|
Dilacort 5mg gastro-resistant tablets (Teva)
0603020T0BPABAG
|
Dilacort (Teva UK Ltd) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 1.5mg/5ml oral liquid
0603020T0AABBBB
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 1.67mg/5ml oral liquid
0603020T0AABJBJ
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 10mg/5ml oral liquid
0603020T0AABCBC
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 1mg/5ml oral liquid
0603020T0AABFBF
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 2.5mg/5ml oral liquid
0603020T0AABIBI
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 25mg/5ml oral liquid
0603020T0AABDBD
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 2mg/5ml oral suspension
0603020T0AABEBE
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
|
Prednisolone 50mg tablets
0603020T0AAAEAE
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.